Is there a Role for MRI in the Preoperative Assessment of Patients with DCIS?
- 9 March 2010
- journal article
- Published by Springer Science and Business Media LLC in Annals of Surgical Oncology
- Vol. 17 (9), 2395-2400
- https://doi.org/10.1245/s10434-010-1000-9
Abstract
Breast magnetic resonance imaging (MRI) is used to identify residual and additional disease in patients with invasive carcinoma. The use of MRI in assessing extent of disease for ductal carcinoma in situ (DCIS) is less well defined. This study assessed the value of MRI in the preoperative evaluation of DCIS. We identified 98 patients with DCIS in 2007. Of these, 63 underwent stereotactic biopsy, followed by MRI. There were 35 who underwent stereotactic biopsy alone. Concordance between MRI and histopathology was defined as the presence or absence of residual disease. There was no significant difference in mastectomy rates between the MRI and non-MRI group (20.3% vs 25.7%, P = .62). In patients undergoing breast-conserving surgery (BCS), there were fewer positive margins in the MRI versus the non-MRI group (21.2% vs 30.8%, P = .41). Of the 64 cases that underwent preoperative MRI, 43 (67.2%) were concordant. Also, 15 of 43 cases (34.8%) had MRI results that accurately predicted pathologic size. In 28 of 43 patients (65.2%), MRI overestimated disease in 20, by a mean of 1.97 cm. In patients with MRI tumor size >2 cm, MRI overestimated disease by a mean of 3.17 cm. Of the 64 cases, 21 (32.8%) were discordant. Also, 10 of 21 (47.6%) had a positive MRI and no residual disease on histopathology, and 11 of 21 (52.3%) had negative MRI and residual disease on pathology. MRI does not accurately predict extent of disease in patients with extensive DCIS. In patients with MRI tumor size ≤2 cm, MRI may assist in surgical planning. MRI results in patients with DCIS should be interpreted with caution; decision for mastectomy should not be made on MRI findings alone.Keywords
This publication has 18 references indexed in Scilit:
- Breast Cancer: Pre- and Postoperative Imaging for StagingSurgical Oncology Clinics of North America, 2007
- Contrast-Enhanced Breast MRI in Patients with Suspicious Microcalcifications on Mammography: Results of a Multicenter TrialAmerican Journal of Roentgenology, 2006
- Determination of the Presence and Extent of Pure Ductal Carcinoma in Situ by Mammography and Magnetic Resonance ImagingThe Breast Journal, 2005
- Sensitivity of MRI Versus Mammography for Detecting Foci of Multifocal, Multicentric Breast Cancer in Fatty and Dense Breasts Using the Whole-Breast Pathologic Examination as a Gold StandardAmerican Journal of Roentgenology, 2004
- Magnetic resonance imaging in patients diagnosed with ductal carcinoma-in-situ: value in the diagnosis of residual disease, occult invasion, and multicentricity.Annals of Surgical Oncology, 2003
- Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.Journal of Clinical Oncology, 1998
- Ductal carcinoma in situ of the breast: Progress and controversyCurrent Problems in Surgery, 1996
- Ductal carcinoma in situ: MR imaging-histopathologic correlation.Radiology, 1995
- MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation.Radiology, 1993
- Histologic multifocality of tis, T1–2 breast carcinomas implications for clinical trials of breast-conserving surgeryCancer, 1985